Setmelanotide receives orphan designation in US for the treatment of Alström Syndrome

Alström syndrome is an ultra-rare genetic disorder that affects multiple organ systems, with main symptom of this condition being insatiable hunger. This selective agonist of the MC4 receptor is currently being investigated in phase II studies.


Biospace Inc.